CSGP vs EBS
CoStar Group Inc (CSGP) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CSGP and EBS stock pages for the full models.
Not investment advice.